B. Sobel

发表

Rubredoxin: a new electron transfer protein from Clostridium pasteurianum.

W. Lovenberg, B. Sobel, 1965, Proceedings of the National Academy of Sciences of the United States of America.

Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis.

B. Sobel, S. Fujii, W. Hopkins, 1991, Circulation.

Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.

A. Schwartz, D. Owensby, P. A. Morton, 1989, The Journal of biological chemistry.

Synergistic induction of plasminogen activator inhibitor type-1 in HEP G2 cells by thrombin and transforming growth factor-beta.

S. Fujii, W. Hopkins, B. Sobel, 1992, Blood.

Enhanced RNA polymerase activity in skeletal muscle undergoing hypertrophy.

S. Kaufman, B. Sobel, B. Sobel, 1970, Archives of biochemistry and biophysics.

Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I.

B. Sobel, R. Levine, 2001, Coronary artery disease.

Receptor-mediated endocytosis of tissue-type plasminogen activator by the human hepatoma cell line Hep G2.

A. Schwartz, D. Owensby, B. Sobel, 1988, The Journal of biological chemistry.

Characteristics of Clostridium pasteurianum ferredoxin in oxidation-reduction reactions.

W. Lovenberg, B. Sobel, 1966, Biochemistry.

Fluorescent alkylating agents. 1-(beta-chloroethyl)bisbenzimidazoles.

K. Tsou, B. Sobel, D. J. Rabiger, 1969, Journal of Medicinal Chemistry.